MDGL Stock-Based Compensation
Madrigal Pharmaceuticals Inc · Stock-Based Compensation
MDGL Stock-Based Compensation
Latest reported$95.64Mperiod ending
MDGL TTM Stock-Based Comp ($5.42M → $95.64M)
TTM stock-based compensation
High-resolution chart · PNG
MDGL stock-based compensation history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 95,641,000 | |
| 85,429,000 | |
| 72,342,000 | |
| 90,018,000 | |
| 81,664,000 | |
| 80,909,000 | |
| 79,880,000 | |
| 77,056,000 | |
| 71,818,000 | |
| 58,387,000 | |
| 49,735,000 | |
| 42,965,000 | |
| 38,427,000 | |
| 35,398,000 | |
| 31,625,000 | |
| 29,899,000 | |
| 28,019,000 | |
| 28,254,000 | |
| 26,873,000 | |
| 25,651,000 | |
| 24,470,000 | |
| 21,980,000 | |
| 20,730,000 | |
| 19,628,000 | |
| 19,517,000 | |
| 21,583,000 | |
| 22,759,000 | |
| 23,846,000 | |
| 23,872,000 | |
| 18,344,000 | |
| 13,489,000 | |
| 9,317,000 | |
| 5,370,000 | |
| 3,819,000 | |
| 3,254,000 | |
| 2,883,235 | |
| 8,964,174 | |
| 8,833,174 | |
| 8,679,174 | |
| 8,681,939 | |
| 2,740,000 | |
| 3,038,000 | |
| 4,300,000 | |
| 5,487,000 | |
| 5,885,000 | |
| 6,555,000 | |
| 7,431,000 | |
| 7,205,000 | |
| 7,322,000 | |
| 7,400,000 | |
| 6,030,000 | |
| 5,453,000 | |
| 4,571,000 | |
| 3,711,000 | |
| 3,322,000 | |
| 3,207,000 | |
| 3,273,000 | |
| 3,354,000 | |
| 3,354,000 | |
| 3,369,000 | |
| 3,465,000 | |
| 3,788,000 | |
| 4,048,000 | |
| 4,300,000 | |
| 4,589,000 | |
| 4,501,000 | |
| 4,579,000 | |
| 11,036,000 | |
| 9,784,000 | |
| 8,737,000 | |
| 9,708,000 | |
| 7,553,000 | |
| 7,553,000 | |
| 7,553,000 | |
| 5,417,000 | |
| 0 | |
| 0 |